SonoThera · 8 hours ago
Histology Research Associate (contract)
SonoThera is a venture capital-backed early-stage biopharmaceutical company developing ultrasound-guided non-viral targeted gene therapies. The Gene Therapy group is seeking a Research Associate to support drug development efforts by establishing and executing a tissue processing pipeline for histology analysis.
BiopharmaBiotechnologyGeneticsMedical
Responsibilities
Establish and execute a tissue processing pipeline on-site at SonoThera
Work across teams to receive mouse, rat, and NHP tissue samples and prepare them for histology analysis
Qualification
Required
Bachelor's Degree with 0-2 years of relevant experience
Experience in processing and tracking histology samples
Strong communication, critical thinking, and problem-solving skills
Experience performing FFPE and OCT sample processing, embedding and sectioning for a variety of tissues and species
Experience performing special stains such as H&E, PAS, Trichrome, etc
Training in sample management workflows
Exceptional organizational skills including SOP documentation, and record-keeping using ELN platforms such as Benchling
Preferred
Industry experience preferred
Experience preparing slides for DNA and RNA analysis (RNAscope, Visium, etc.) is a plus
Benefits
Access to a 24-hour onsite gym
Comprehensive medical, dental, and vision
Equity and ownership in a fast-growing company
Commuting stipend based on your geographical location
401(k) Match: SonoThera offers a company match
All full-time employees are eligible for our flexible time off policy
Company
SonoThera
SonoThera is a biotechnology company that creates non-viral genetic therapies using ultrasound.
H1B Sponsorship
SonoThera has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (5)
Funding
Current Stage
Early StageTotal Funding
$60.75MKey Investors
ARCH Venture Partners
2022-12-05Series A· $60.75M
Leadership Team
Recent News
BioWorld Financial Watch
2026-01-15
2026-01-09
Company data provided by crunchbase